Bayer’s supervisory board is due to discuss and vote in the next few days on a settlement of thousands of claims by plaintiffs that exposure to Roundup caused their cancer, a German business publication reported Tuesday.
To view this article, please
login. If you are not a current subscriber, you may sign up for a trial or view other subscription options
here.
